STAT+: Pharmalittle: Cancer drug trial yields remission in every patient; Novartis data hacked by extortionists
In results called unprecedented, an experimental GSK treatment shrank locally advanced rectal cancer until it was undetectable in all 14 patients in a clinical trial.
